Women at high lifetime breast cancer risk might benefit from breast MRI screening in addition to routine mammography, but a new study shows that breast MRI is greatly under-utilised even though access is widely available.
The study of more than 422,000 women is published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website.
Christoph Lee, MD, University of Washington School of Medicine, Seattle, and a team of researchers coauthored the study entitled "Under-utilisation of Supplemental MRI Screening Among Patients at High Breast Cancer Risk."
They reported that while nearly 44% of women at high (>20%) lifetime breast cancer risk had mammography performed at a facility with on-site breast MRI screening available, only 6.6% of the high-risk women underwent breast MRI screening.
"Breast MRI screening may benefit women with a high lifetime risk of breast cancer through earlier cancer detection," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.
"A greater understanding is needed of why this widely available resource is not being fully utilised to screen high-risk women."
Source: Mary Ann Liebert, Inc.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.